Atomization inhalation of terbutaline and budesonide efficiently improved immunity and lung function of AECOPD patients

Cellular and Molecular Immunology

Volumn 5, Issue 4, 2008, Pages 287-291

  Xiong, Guilan ^a   Xu, Lijun ^a   Wei, Liu ^a   Li, Xiaodan ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

AECOPD; C reactive protein; eosinophil; IL 2; T lymphocyte subset

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; C REACTIVE PROTEIN; INTERLEUKIN 2; TERBUTALINE;

AGED; ARTICLE; BLOOD; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION;

ADMINISTRATION, INHALATION; AGED; BRONCHIAL HYPERREACTIVITY; BRONCHODILATOR AGENTS; BUDESONIDE; C-REACTIVE PROTEIN; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; T-LYMPHOCYTE SUBSETS; TERBUTALINE;

EID: 55249121707     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.35     Document Type: Article

References (18)

1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269-280. (Pubitemid 30490396)
2. Michaud CM, Murray CJ, Bloom BR. Burden of disease: implications for future search. JAMA. 2001;285:535-539. (Pubitemid 32656319)
3. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet. 1997;349:1498-1504.
4. Liu H, Zhang C. The bronchitis and the change of cytokine levels in chronic obstructive pulmonary disease. Zhongguo Zong He Lin Chuang. 2004;20:323-324.
5. Hu SX, Wu RF. The characterization of small airway function and airway response in asthma and chronic obstructive pulmonary disease patients. Lin Chuang Hui Cui. 2007;22: 96-97.
6. Szafranski W, Cukier A, Ramirez A, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J. 2003;21:74-81. (Pubitemid 36150304)
7. Reynolds NA, Perry CM, Keating GM, et al. Budesonide/ formoterol: in chronic obstructive pulmonary disease. Drugs. 2004;64:431-441. (Pubitemid 38333656)
8. Sin DD, Man SP. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients? Curr Opin Pulm Med. 2007;6:309-316.
9. Small S. Review: Long acting β2-agonists and inhaled corticosteroids reduce exacerbations in chronic obstructive pulmonary disease. Evid Based Nurs. 2004;7:87.
10. Hattotuwa KL, Gizycki MJ, Ansari TW, Jeffery PK, Barnes NC. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebocontrolled biopsy study. Am J Respir Crit Care Med. 2002; 165:1592-1596. (Pubitemid 34693937)
11. Ollenschlager G, Kopp I, Lelgemann M. The German program for disease management guidelines: COPD guideline 2006. Med Klin (Munich). 2007:102:50-55. (Pubitemid 46142566)
12. Sin DD, Wu L, Anderson JA, et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax. 2005;60:992-997. (Pubitemid 41705466)
13. Sutherland ER, Allmers H, Ayas NT, et al. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax. 2003;58:937-941. (Pubitemid 37392802)
14. Wedzicha JA, Calverley PM, Seemungal TA, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med. 2008;177:19-26.
15. Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med. 2002;113:59-65. (Pubitemid 34775161)
16. Highland KB, Strange C, Heffner JE. Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med. 2003;138:969-973.
17. Sutherland ER, Allmers H, Ayas NT, et al. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax. 2003;58:937-941. (Pubitemid 37392802)
18. Celli BR, MacNee W, ATS/ERS task force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:932-946. (Pubitemid 38807371)